Abstract
This study was undertaken to compare the effects of chronic angiotensin-converting enzyme (ACE) inhibition on blood pressure (BP) and renal hemodynamics in older black and nonblack hypertensive patients with chronic renal insufficiency. A multicenter, placebo lead-in double-blind, parallel group study was performed to compare the antihypertensive efficacy and renal hemodynamic response to the once-daily ACE inhibitor fosinopril (n = 14) and lisinopril (n = 13) over a 22-week period. The study goal was to lower diastolic blood pressure (DBP) to 90 mm Hg or less. Furosemide was added after 6 weeks if blood pressure goal was not achieved. At outpatient clinics at university medical centers, 27 older hypertensive patients (> or = 45 years; 12 blacks, 15 nonblacks; 19 male, eight female) with DBP of 95 mm Hg or higher and 4-hour creatinine clearance 20 to 70 mL/min/1.73 m2 were studied. Changes (delta) from baseline in BP, glomerular filtration rate (GFR), and renal plasma flow (RPF) were measured. Mean systolic blood pressure (SBP) and DBP decreased significantly and to a similar extent in randomized groups: fosinopril (mean +/- SEM) delta DBP at 6 weeks was -13 +/- 2 (P < 0.0001; 95% CI, -16 to -9) and at 22 weeks was -12 +/- 2 (P...Continue Reading
References
Aug 1, 1992·Kidney International·P ZucchelliR Gaggi
Jul 1, 1992·American Journal of Hypertension·A L KamperP P Leyssac
Oct 1, 1991·Annals of Internal Medicine·R D TotoW A Pettinger
Nov 15, 1991·Annals of Internal Medicine·A B ChapmanR W Schrier
Nov 1, 1990·Kidney International·T BochicchioJ Herrera-Acosta
Jan 1, 1990·Nephron·R D SmithB A Price
Sep 15, 1989·Annals of Internal Medicine·W F KeaneG Povar
Feb 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L M RuilopeL Raij
Aug 1, 1985·The Journal of Clinical Investigation·S AndersonB M Brenner
Oct 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J H Bauer, P Gaddy
Jun 1, 1986·The Journal of Clinical Investigation·S AndersonB M Brenner
Jan 1, 1986·Nephron·J H BauerP Gaddy
Aug 20, 1984·The American Journal of Medicine·J H Bauer
Mar 9, 1984·Journal of Chromatography·T PrueksaritanontW L Chiou
Sep 1, 1995·Kidney International·R D TotoW A Pettinger
Jul 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W G Walker
Aug 9, 1993·Archives of Internal Medicine·P M ter Wee, M Epstein
Nov 11, 1993·The New England Journal of Medicine·E J LewisR D Rohde
Jan 15, 1993·Annals of Internal Medicine·B L KasiskeW F Keane
Jan 1, 1993·Journal of the American Society of Nephrology : JASN·P E de JongD de Zeeuw
Apr 1, 1993·The New England Journal of Medicine·B J MatersonJ Gottdiener
Apr 11, 1996·The New England Journal of Medicine·G MaschioP Zucchelli
Citations
Sep 12, 2000·Current Hypertension Reports·A B Fogo
Oct 6, 2017·PloS One·Carmen PinedaIgnacio Lopez
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K R ReddyT Joh
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Pawana SharmaCorri Black
Jul 5, 2018·British Journal of Clinical Pharmacology·Seyyed-Reza Sadat-EbrahimiAmir Azarpazhooh
Sep 12, 1998·Kidney International·A C SmithG L Bakris